Syrhatech completes CHF 4.5 million financing round

Syrhatech, a CDMO specializing in injectable medical devices based on hyaluronic acid, has closed an investment of CHF 4.5 million from strategic investors. The funds will be used to strengthen its R&D team in Geneva and deploy new production capacity at its plant in Chambéry, France.

“This investment will enable Syrhatech to strengthen its R&D team at its site in Geneva, Switzerland, and to deploy a new production capacity at its plant in Chambéry, France.”syrhatech.com

• 1 source
• syrhatech.comSyrhatech completes a financinground of CHF 4.5 million | Syrhatech CDMOApr 24, 2025

Summarized from public sources; check the original articles before acting on it.